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Progress in imaging techniques has brought a solution to the problem of the
early diagnosis of breast cancer. An interesting case of breast cancer is present-
ed here, pictures of the malignant tumour are demonstrated and the usefulness
of new diagnostic methods analysed. The presentation of this case may contri-
bute to greater effectiveness in early breast cancer detection.
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INTRODUCTION
Changes in the structure of the mammary gland
are related to age, hormonal stage and medicine in-
take. This variety of factors contributes to the difficul-
ties in the diagnosis of breast disease and requires prop-
er additional investigation by means of imaging. The
introduction of mammography as a screening test in
breast cancer has diminished mortality by 30%. The
development of the ultrasound examination has helped
enhance the sensitivity of mammography by 10% [6].
Changes in grades T0 and T1 are most often clin-
ically “mute” and their detection is possible only by
using methods of imaging examination, which be-
come a main baseline diagnostic in early breast can-
cer. The method of choice is mammography. This
presents a great variety in sensitivity in different age
groups. Its sensitivity among young women with
a high density in the structure of mammary glands
and among older women with adipose structure
is 30% and 80% respectively [5].
The aim of the study was to reveal the great va-
lue of ultrasound of the mammary gland as an addi-
tional examination next to mammography in the
diagnostics of breast cancer.
CASE REPORT
An alteration (8 mm) was disclosed in mammo-
graphy performed on a patient aged 68. Two experien-
ced radiologists described it as a benign, well-se-
parated lesion with a cyst feature (Fig. 1, 2), and it
was not considered as potentially malign. Mam-
mosonography was performed as a routine investi-
gation (Fig. 3) and this disclosed a well-separated,
hypoechogenic lesion. Thin needle aspiration biopsy
(BACC) was performed. Cytological examination of
the aspirated fluid revealed neoplastic cells. The pa-
tient was operated on and ca ductale invasivum
mammae sin. was found in the post-operative histo-
pathological examination.
RESULTS AND DISCUSSION
This case report indicates the important role of
new imaging examinations, the great progress made
in methods of diagnosis and the increase in their
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sensitivity. There are attempts to enhance the sensi-
tivity of mammography by additional examination,
as, for example, mammosonography. A system of
evaluating x-ray images by two radiologists indepen-
dently (double reading) has been introduced, which
has increased perception in cases of small foci of
micro calcification and thus enhanced the detec-
tability of breast cancer by 10% [6]. The next step in
the improvement of the diagnostics of breast can-
cer has been the development of a computer-aided
detection system (CADS) [7], which has also en-
hanced cancer detectability by 10.5–19.5%. The
diagnostic value of digital mammography (DW) has
not yet been assessed [4].
It seems that the latest diagnostic methods for
breast cancer, such as resonance-magnetic mam-
mography (MRM) and positron emission tomogra-
phy (PET), will soon be commonly available. MRM is
a dynamic examination, which distinguishes neoplas-
tic lesions from others by analysing the degree of
signal amplification after contrast administration
(Gd-DPTA). After 1-minute malignant tumors under-
go great augmentation and then the contrast is very
quickly removed from the neoplastic focus [2]. This
method can be used in the detection of an alteration
above 3 mm with greater vascularisation (which
results in contrast accumulation) than benign chan-
ges [3]. However, in the case of neoplasm in situ or
that of small invasive cancer this method is not suf-
ficient. MRM is mainly used to evaluate the extent
of a primary neoplastic process, for example infiltra-
tion of the thoracic wall or metastasis to the lym-
phatic nodes. This information is essential in quali-
fying a patient for a sparing operation.
Positron emission tomography (PET), like MRM,
is also a dynamic method and is based on the in-
creased uptake of 18 F-fluorodeoxyglucose (FDG)
Figure 1. Patient’s mammography (MLO projection).
Figure 3. Patient’s ultrasonography.
Figure 2. Patient’s mammography (C-C projection).
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contrast in cells of malignant neoplasm. This meth-
od can detect a primary neoplasmatic focus as well
as metastases to the lymph nodes and to other or-
gans. Unfortunately, due to the high costs of this
examination, it is not commonly available [1]. PET,
along with computer tomography or nuclear mag-
netic resonance, may constitute a breakthrough in
the early diagnostic of breast cancer [1].
The development of new improved diagnostic
methods in breast cancer totally changes the thera-
peutic process and prognosis. As a result of these
new techniques there is hope for a complete cure or
a prolongation of life.
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